The Ethnoracial Diversity of Diabetes: Insights into Epidemiology, Genetics, Disease Management, and Personalized Therapies

Dear Colleagues,

Diabetes mellitus exhibits marked disparities in prevalence, progression, and outcomes across ethnoracial populations, driven by complex interactions between genetic predisposition, environmental exposures, and social determinants of health. Understanding these differences is critical for advancing personalized medicine, as one-size-fits-all approaches often fail to address the unique biological and contextual needs of diverse groups. This Special Issue explores the multifaceted role of ethnoracial diversity in diabetes, spanning epidemiology, genetics, clinical management, and therapeutic innovation.

This issue highlights research that uncovers population-specific patterns in diabetes incidence, prevalence, frequency of complications, and modalities and outcomes of management; identifies genetic and epigenetic variants associated with disease risk or treatment response; and evaluates how cultural, socioeconomic, and structural factors influence disease frequency, care access, and adherence. Contributions may examine how ethnoracial diversity shapes pathophysiological pathways (e.g., insulin resistance and β-cell dysfunction) or impacts the efficacy of pharmacotherapies, lifestyle interventions, or precision screening tools, as well as the description and integration of epidemiological data, genomic insights, and real-world clinical experiences. This issue aims to bridge gaps in the ethnographic dimention of the frecuency diabetes, management outcomes, and personalized care for understudied populations.

We invite submissions of original research and reviews that advance our understanding of diabetes through the lens of ethnoracial diversity. Studies focusing on health disparities, population-specific biomarkers, or tailored interventions are particularly encouraged. Together, these contributions will inform strategies to improve prevention, management, and outcomes for all individuals, regardless of their background, by embedding diversity into the foundation of diabetes care and research.

Dr. Alberto Barcelo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.